Two years after spinning off its $15 billion consumer health unit as Kenvue, Johnson & Johnson is slimming down again by unveiling a plan to separate its orthopedics business, transforming it into a standalone company. J&J expects to complete the separation within 18 to 24 months, with the new company dubbed DePuy Synthes. The focus of J&J’s Medtech business away from its orthopedics unit has been illustrated by recent acquisitions of cardiovascular device makers Abiomed for $16.6 billion and Shockwave Medical for $13.1 billion.
Read the full article: J&J Move to Spin Off Orthopedics Unit Is ‘All About Shrinking to Grow Faster,’ Exec Says //
Source: https://www.fiercebiotech.com/medtech/jj-spinning-orthopedics-unit-all-about-shrinking-grow-faster